
IVF Hartmann Holding AG VBSN.SW
VBSN.SW
IVF Hartmann Holding AG CLTN.SW
COLTENE Holding AG DOCM.SW
DocMorris AG NWRN.SW
Newron Pharmaceuticals S.p.A. ASCN.SW
Ascom Holding AG SANN.SW
Santhera Pharmaceuticals Holding AG MOLN.SW
Molecular Partners AG BSLN.SW
Basilea Pharmaceutica AG SHLTN.SW
SHL Telemedicine Ltd. RLF.SW
Relief Therapeutics Holding AG
IVF Hartmann Holding AG CLTN.SW
COLTENE Holding AG DOCM.SW
DocMorris AG NWRN.SW
Newron Pharmaceuticals S.p.A. ASCN.SW
Ascom Holding AG SANN.SW
Santhera Pharmaceuticals Holding AG MOLN.SW
Molecular Partners AG BSLN.SW
Basilea Pharmaceutica AG SHLTN.SW
SHL Telemedicine Ltd. RLF.SW
Relief Therapeutics Holding AG
Performance
Periode | VBSN.SW | CLTN.SW | DOCM.SW | NWRN.SW | ASCN.SW | SANN.SW | MOLN.SW | BSLN.SW | SHLTN.SW | RLF.SW |
---|---|---|---|---|---|---|---|---|---|---|
6M | -14.47 % | -25.58 % | -39.41 % | 109.47 % | 21.09 % | -25.82 % | -13.53 % | 17.73 % | -42.44 % | 15.97 % |
YTD | -9.33 % | -10.93 % | -70.25 % | 60.73 % | -16.04 % | -28.08 % | -35.78 % | 16.02 % | -51.44 % | -37.27 % |
1Y | -3.55 % | -12.31 % | -80.54 % | 58.04 % | -33.33 % | 13.41 % | -50.09 % | 7.00 % | -52.42 % | -54.75 % |
3Y | 26.51 % | -41.08 % | -77.11 % | 989.23 % | -40.37 % | 73.33 % | -56.23 % | 8.94 % | -92.72 % | -73.96 % |
5Y | -18.56 % | -35.72 % | -97.54 % | 686.67 % | -69.62 % | -67.85 % | -81.11 % | 2.88 % | -80.97 % | -98.60 % |
10Y | -15.84 % | -23.43 % | -96.09 % | -52.00 % | -80.44 % | -98.91 % | -91.63 % | -53.70 % | -87.92 % | -82.75 % |
From the beginning | 1 450.74 % | -51.34 % | -96.09 % | -75.59 % | -99.74 % | -98.85 % | -87.47 % | -52.00 % | -97.32 % | -99.98 % |